The first training for certification will include a
|
The first training for certification will include a
|
HCV Info Fact 9 Nov 2003 Antiviral therapy has steadily improved over the last decade. The side effect profile of interferon-based therapies has remained largely unchanged. Recent data have suggested that improved adherence to combination regimens will favorable affect sustained virologic response rates. The minimal criteria recommended by the National Institutes of Health for candidates…
TRIPS No Longer Operating This past Spring TRIPS the project that assists methadone patients to find an alternative site while traveling was closed. It happened very quickly and as you would expect created problems immediately. NAMA began receiving calls as early as March from patients trying to locate a program in the area that they…
Information on NAMA’s website is not intended as medical advice for individual problems. Appropriate medical professionals should be consulted regarding addiction and addiction recovery. Pharmacologic Agents Clinical Signs and Symptoms Comments Drugs That Decrease Methadone Levels Rifampin, phenytoin, carbamazepine, butabarbital sodium, mephobarbital, phenobarbital, secobarbital, ethanol (chronic), disulfiram, urinary acidifiers, ascorbic acid Withdrawal signs Disulfiram…
October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA), will now become…
Paul Edward Bowman (1963-2021) December 3, 2021 NAMA Recovery is saddened to report the passing of a long-standing member of our Board of Directors. Paul Edward Bowman, Jr, 58, passed away on November 22, 2021. Paul was born in Boston, MA and lived most of his life in Quincy, MA. Paul served Massachusetts residents for…
Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award! NAMA Recovery AATOD Lane Holden Award May 1, 2022 | 0 Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive…